245 related articles for article (PubMed ID: 25149363)
1. CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells.
Wei Q; Zhang F; Richardson MM; Roy NH; Rodgers W; Liu Y; Zhao W; Fu C; Ding Y; Huang C; Chen Y; Sun Y; Ding L; Hu Y; Ma JX; Boulton ME; Pasula S; Wren JD; Tanaka S; Huang X; Thali M; Hämmerling GJ; Zhang XA
Circulation; 2014 Oct; 130(17):1493-504. PubMed ID: 25149363
[TBL] [Abstract][Full Text] [Related]
2. CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts.
Xu C; Zhang YH; Thangavel M; Richardson MM; Liu L; Zhou B; Zheng Y; Ostrom RS; Zhang XA
FASEB J; 2009 Oct; 23(10):3273-88. PubMed ID: 19497983
[TBL] [Abstract][Full Text] [Related]
3. CD82 and Gangliosides Tune CD81 Membrane Behavior.
Fernandez L; Malrieu M; Bénistant C; Dosset P; Rubinstein E; Odintsova E; Berditchevski F; Milhiet PE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445169
[TBL] [Abstract][Full Text] [Related]
4. KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state.
Lee JW; Hur J; Kwon YW; Chae CW; Choi JI; Hwang I; Yun JY; Kang JA; Choi YE; Kim YH; Lee SE; Lee C; Jo DH; Seok H; Cho BS; Baek SH; Kim HS
J Hematol Oncol; 2021 Sep; 14(1):148. PubMed ID: 34530889
[TBL] [Abstract][Full Text] [Related]
5. Gangliosides play an important role in the organization of CD82-enriched microdomains.
Odintsova E; Butters TD; Monti E; Sprong H; van Meer G; Berditchevski F
Biochem J; 2006 Dec; 400(2):315-25. PubMed ID: 16859490
[TBL] [Abstract][Full Text] [Related]
6. An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82.
Li W; Wang Q; Qi X; Lu H; Chen Y; Shi J; Wang F; Wang Z; Lu Y; Lu Z; Yan Q; Wang C; Gao SJ; Lu C
Cell Death Differ; 2020 Dec; 27(12):3289-3306. PubMed ID: 32555380
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD82 Organizes Dectin-1 into Signaling Domains to Mediate Cellular Responses to
Tam JM; Reedy JL; Lukason DP; Kuna SG; Acharya M; Khan NS; Negoro PE; Xu S; Ward RA; Feldman MB; Dutko RA; Jeffery JB; Sokolovska A; Wivagg CN; Lassen KG; Le Naour F; Matzaraki V; Garner EC; Xavier RJ; Kumar V; van de Veerdonk FL; Netea MG; Miranti CK; Mansour MK; Vyas JM
J Immunol; 2019 Jun; 202(11):3256-3266. PubMed ID: 31010852
[TBL] [Abstract][Full Text] [Related]
8. The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density.
Termini CM; Cotter ML; Marjon KD; Buranda T; Lidke KA; Gillette JM
Mol Biol Cell; 2014 May; 25(10):1560-73. PubMed ID: 24623721
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity.
Feng J; Huang C; Wren JD; Wang DW; Yan J; Zhang J; Sun Y; Han X; Zhang XA
Cancer Metastasis Rev; 2015 Dec; 34(4):619-33. PubMed ID: 26335499
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains.
Nomura S; Iwata S; Hatano R; Komiya E; Dang NH; Iwao N; Ohnuma K; Morimoto C
Biochem Biophys Res Commun; 2016 May; 474(1):111-117. PubMed ID: 27103437
[TBL] [Abstract][Full Text] [Related]
11. A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.
Li W; Hu M; Wang C; Lu H; Chen F; Xu J; Shang Y; Wang F; Qin J; Yan Q; Krueger BJ; Renne R; Gao SJ; Lu C
Oncogene; 2017 Sep; 36(38):5407-5420. PubMed ID: 28534512
[TBL] [Abstract][Full Text] [Related]
12. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
Neumann E; Schwarz MC; Hasseli R; Hülser ML; Classen S; Sauerbier M; Rehart S; Mueller-Ladner U
Ann Rheum Dis; 2018 Nov; 77(11):1619-1626. PubMed ID: 29980577
[TBL] [Abstract][Full Text] [Related]
14. CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction.
Zhang Q; Chen L; Huang L; Cheng H; Wang L; Xu L; Hu D; He C; Fu C; Wei Q
Mol Med; 2022 Dec; 28(1):145. PubMed ID: 36463112
[TBL] [Abstract][Full Text] [Related]
15. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts.
Lee JL; Wang MJ; Sudhir PR; Chen JY
Mol Cell Biol; 2008 Sep; 28(18):5710-23. PubMed ID: 18644869
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract][Full Text] [Related]
17. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
[TBL] [Abstract][Full Text] [Related]
18. Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
Pehkonen H; Lento M; von Nandelstadh P; Filippou A; Grénman R; Lehti K; Monni O
Cell Commun Signal; 2018 Jul; 16(1):41. PubMed ID: 30005669
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanin CD82 interaction with cholesterol promotes extracellular vesicle-mediated release of ezrin to inhibit tumour cell movement.
Huang C; Hays FA; Tomasek JJ; Benyajati S; Zhang XA
J Extracell Vesicles; 2020; 9(1):1692417. PubMed ID: 31807237
[TBL] [Abstract][Full Text] [Related]
20. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.
Liu WM; Zhang F; Moshiach S; Zhou B; Huang C; Srinivasan K; Khurana S; Zheng Y; Lahti JM; Zhang XA
PLoS One; 2012; 7(12):e51797. PubMed ID: 23251627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
